Get the Stockscreener App
22.83
1.59%
-0.37
After Hours:
22.79
-0.04
-0.18%
Progyny Inc stock is traded at $22.83, with a volume of 745.71K.
It is down -1.59% in the last 24 hours and up +4.20% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$23.20
Open:
$23.36
24h Volume:
745.71K
Relative Volume:
0.71
Market Cap:
$1.96B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
36.24
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-0.65%
1M Performance:
+4.20%
6M Performance:
-1.81%
1Y Performance:
-21.33%
1-Day Range:
$22.82
$23.51
1-Week Range:
$22.82
$23.67
52-Week Range:
$13.39
$29.65
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
22.83 | 1.99B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
261.07 | 255.92B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
292.17 | 78.11B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
60.00 | 75.45B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
288.73 | 64.40B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
232.62 | 27.94B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny, Inc. (PGNY) Stock Analysis: Unpacking the 15% Upside Potential and Analyst Consensus - DirectorsTalk Interviews
What risks could impact Progyny Inc. stock performanceTop Gaining Picks With Entry Signals Identified - metal.it
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
What makes Progyny Inc. stock price move sharplyStock Market Forecasts From AI Tools - jammulinksnews.com
What is Progyny Inc. company’s growth strategyRealize consistent double-digit growth - jammulinksnews.com
When is Progyny Inc. stock expected to show significant growthInvest smarter with daily stock recommendations - jammulinksnews.com
Is Progyny Inc. stock overvalued or undervaluedGet exclusive access to premium stock research - jammulinksnews.com
How does Progyny Inc. compare to its industry peersMassive portfolio appreciation - jammulinksnews.com
What are the technical indicators suggesting about Progyny Inc.Free Capital Allocation Plans - jammulinksnews.com
Sectors Driving Future Growth for Progyny Inc. StockHigh Return Intraday Picks - metal.it
Should You Think About Buying Progyny, Inc. (NASDAQ:PGNY) Now? - 富途牛牛
What analysts say about Progyny Inc. stockOverwhelming profit margins - PrintWeekIndia
Progyny Inc. Stock Analysis and ForecastFree Technical Analysis Support - Autocar Professional
Should I buy Progyny Inc. stock before earningsUnstoppable trading performance - jammulinksnews.com
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
What drives Progyny Inc. stock priceBreakthrough financial growth - Autocar Professional
Progyny Investors Wait For Growth To Catch Up To Hope - Finimize
Is Progyny Inc. a good long term investmentExplosive trading opportunities - jammulinksnews.com
When (PGNY) Moves Investors should Listen - news.stocktradersdaily.com
Progyny Stock Gains 3.1% Amid Market Rally and Earnings OptimismNews and Statistics - IndexBox
Why Progyny (PGNY) Stock Is Up Today - Yahoo Finance
Why Progyny (PGNY) Stock Is Falling Today - Yahoo Finance
Truist Securities Maintains Hold Rating on Progyny (PGNY), Raise - GuruFocus
Progyny: Truist Securities Maintains Hold, Raises PT to $27 from $24. - AInvest
Progyny (PGNY) Price Target Increased Amid Mixed Investor Sentim - GuruFocus
Progyny partners with Oura for women’s health monitoring By Investing.com - Investing.com Nigeria
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):